Skip to content

Patients With Implantable Cardiac Devices Requiring a Nuclear Magnetic Resonance

Spanish Registry of Patients With Implantable Cardiac Devices That Require a Diagnostic Imaging Test With Nuclear Magnetic Resonance

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04330898
Acronym
RESONANCE
Enrollment
1248
Registered
2020-04-02
Start date
2017-05-02
Completion date
2020-07-30
Last updated
2020-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implantable Cardiac Device. Patients With a NMR Indication

Keywords

Peacemaker, implantable cardioverter-defibrillator, Nuclear Magnetic Resonance

Brief summary

The general objective of this registry is to study the number of patients carrying an implantable cardiac device that have an indication for an imaging diagnosis based on nuclear magnetic resonance. Is wanted to know the cause of the indication of the diagnostic test based on MRI.

Detailed description

MRI is currently infra indicated in patients with cardiac stimulation devices and for this reason, the request for this imaging technique in these patients is complicated and, often, the MRI-based test is replaced by a CT scan that may not be so beneficial for the diagnosis. Current data indicate that, with cardiological control and maintaining basic safety precautions, MRI could be performed in patients with peacemakers and Implantable Cardioverter Defibrillators (ICD) that require it for clinical reasons, although it should be noted that currently, due to lack of data published, the absolute safety of an MRI in these patients and the protocol used in each case cannot be guaranteed. This registry proposal is to have data of all patients implanted with Biotronik cardiac stimulation devices and evaluate how many of them have an indication for an MRI-based diagnostic test, how many of them are already undergoing this diagnostic test, how many are given an tomography as an alternative to avoid subjecting patients to an MRI

Interventions

DEVICEBiotronik peacemakers, implantable cardioverter-defibrillators and cardiac resynchronizers

Any of these Biotronik cardiac stimulation devices with the Home Monitoring function activated for the remote control of patients

Sponsors

Trialance SCCL
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients carrying a cardiac stimulation device * Patients able to understand the nature of the procedure * Patients who give informed consent

Exclusion criteria

* Epicardial cables * Abandoned cables * Non-BIOTRONIK cables * Age \<18 years * Pregnant and breastfeeding * Subjects with irreversible brain damage caused by a pre-existing brain disease * Heart transplant 6 months prior to recruitment or expected within the next 3 months * Cardiac surgery 3 months prior to recruitment or planned for the next 3 months * Life expectancy less than 12 months

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients with implantable cardiac devices that require a diagnostic test based on MRI1 yearstatistical analysis of the variable

Secondary

MeasureTime frameDescription
Primary indication for MRI1 yearstatistical analysis of the variable
Reasons for not used MRI1 yearstatistical analysis of the variable
Percentage of patients with a non-MRI-based test diagnosis, although they had an indication for an MRI-based diagnostic test because of their disease1 yearstatistical analysis of the variable
Cost effectiveness of the he MRI Autodetect function1 yearstatistical analysis of the variable
Analysis of the differences in the workflow1 yearstatistical analysis of the variable

Countries

Spain

Contacts

Primary ContactXavier Molina Figueras, PharmD, PhD
xmolina@trialance.com+ 34 689900009
Backup ContactMarta Barbacid Hernández, PharmD, MSc
mbarbacid@trialance.com+34 630767668

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026